Skip to Content
Merck
CN
  • L-Homoserine: a novel excreted metabolic marker of hepatitis B abnormally produced in liver from methionine.

L-Homoserine: a novel excreted metabolic marker of hepatitis B abnormally produced in liver from methionine.

Medical hypotheses (2002-05-25)
K G Gazarian, L V Gening, T G Gazarian
ABSTRACT

The hepatitis B infection leads to various profound pathological processes in liver metabolism. Some biochemical alterations detectable by blood analysis are currently used for a preliminary evaluation of the infection. Based on existing data we present here evidence that non-protein amino acid L-homoserine is a pathological, hepatitis B-induced metabolite that is formed and excreted into urine from methionine via splitting S-adenosylmethionine. The urine L-homoserine is proposed as a new marker in the pre-diagnosis examinations that is easier for the clinical analysis than currently used blood test, and is applicable to large-scale epidemiological surveys of the probability of hepatitis B.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
L-Homoserine